P2X(7) receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases

The Journal of Immunology : Official Journal of the American Association of Immunologists
Gloria Lopez-CastejonAnnmarie Surprenant

Abstract

The ATP-gated P2X(7) receptor (P2X(7)R) is a promising therapeutic target in chronic inflammatory diseases with highly specific antagonists currently under clinical trials for rheumatoid arthritis. Anti-inflammatory actions of P2X(7)R antagonists are considered to result from inhibition of P2X(7)R-induced release of proinflammatory cytokines from activated macrophages. However, P2X(7)Rs are also expressed in resting macrophages, suggesting that P2X(7)R may also signal via cytokine-independent mechanisms involved in joint disease. In this study, we examined P2X(7)R function in resting human lung macrophages and mouse bone marrow-derived macrophages and found that ATP induced rapid release of the lysosomal cysteine proteases cathepsin B, K, L, and S and that was independent of the presence of the proinflammatory cytokines IL-1beta and IL-18. Cathepsins released into the medium were effective to degrade collagen extracellular matrix. ATP-induced cathepsin release was abolished by P2X(7)R antagonists, absent from P2X(7)R(-/-) mouse macrophages, and not associated with cell death. Our results suggest P2X(7)R activation may play a novel and direct role in tissue damage through release of cathepsins independently of its proinflammator...Continue Reading

References

May 1, 1991·The Biochemical Journal·H E KhouriR Ménard
Jun 15, 1981·The Biochemical Journal·A Berg, J J Rafter
Nov 19, 1997·Neuropharmacology·G ColloG Buell
Jan 16, 1998·Acta Physiologica Scandinavica·R Sundler
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·R A North, A Surprenant
Jun 13, 2000·Advances in Experimental Medicine and Biology·P SaftigK von Figura
Jun 28, 2000·Journal of the Autonomic Nervous System·G R Dubyak
Jul 8, 2000·Trends in Cell Biology·N W Andrews
May 1, 2001·Biochemical and Biophysical Research Communications·Y HashimotoN Katunuma
Jul 14, 2001·Redox Report : Communications in Free Radical Research·U T BrunkJ W Eaton
Oct 5, 2001·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·G B StroupM Gowen
Dec 1, 2001·Immunity·A MacKenzieA Surprenant
Jan 5, 2002·Life Sciences·R FalchettiG Ravagnan
Sep 25, 2002·Physiological Reviews·R Alan North
Mar 28, 2003·American Journal of Physiology. Cell Physiology·Lalitha GudipatyGeorge R Dubyak
Jul 31, 2003·Biological Chemistry·Shiqing Yan, Bonnie F Sloane
Nov 1, 2003·Bioorganic & Medicinal Chemistry Letters·Andrew BaxterPeter Webborn
Apr 13, 2004·American Journal of Physiology. Cell Physiology·J Michelle Kahlenberg, George R Dubyak
Jul 22, 2004·The Cochrane Database of Systematic Reviews·P C Gotzsche, H K Johansen
Nov 1, 2005·Pharmacology & Therapeutics·Ivar von Kügelgen
Nov 22, 2005·Expert Opinion on Drug Delivery·Dong Wang, Dieter Brömme
Nov 23, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Philip A VerhoefGeorge R Dubyak
Mar 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Davide FerrariFrancesco Di Virgilio
May 5, 2006·Tissue Antigens·T Zavasnik-Bergant, B Turk
Oct 13, 2006·Journal of Leukocyte Biology·Marco E Bianchi
Dec 16, 2006·British Journal of Community Nursing·Maggi Banning
Dec 19, 2006·Cellular Signalling·Samantha F Moore, Amanda B MacKenzie
Feb 8, 2007·Journal of Cell Science·David Brough, Nancy J Rothwell
Feb 22, 2007·Current Pharmaceutical Design·Olga VasiljevaBoris Turk
Jul 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yan QuGeorge R Dubyak
Aug 19, 2007·Trends in Pharmacological Sciences·Francesco Di Virgilio
Nov 6, 2007·Current Opinion in Immunology·Virginie PétrilliJürg Tschopp
Nov 15, 2007·Immunogenetics·Calogero TuloneBenny Chain
Mar 7, 2008·Expert Opinion on Emerging Drugs·Paraskevi V Voulgari
May 14, 2008·Neoplasia : an International Journal for Oncology Research·Ilaria GiustiVincenza Dolo
Jun 24, 2008·Purinergic Signalling·William A CarrollMichael F Jarvis
Oct 15, 2008·Annual Review of Physiology·Annmarie Surprenant, R Alan North

❮ Previous
Next ❯

Citations

Jan 26, 2011·The Journal of Biological Chemistry·Wolfgang NörenbergMichael Schaefer
Jun 14, 2012·PloS One·Eillen J Rodriguez-FrancoLoyda M Melendez
Feb 5, 2014·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Annarosa ArcangeliLapo Bencini
Feb 28, 2014·TheScientificWorldJournal·Torben Madsen KvistNiklas Rye Jørgensen
Sep 13, 2012·Journal of Osteoporosis·Elena AdinolfiAnna Lisa Giuliani
May 31, 2011·Expert Opinion on Investigational Drugs·Sébastien Roger, Pablo Pelegrin
Apr 23, 2011·Expert Opinion on Investigational Drugs·Nishkantha ArulkumaranFrederick Wk Tam
Jul 26, 2012·Journal of Osteoporosis·Alberto Baroja-Mazo, Pablo Pelegrín
Dec 17, 2014·Frontiers in Immunology·Bimal N Desai, Norbert Leitinger
Dec 9, 2016·Scientific Reports·Francisco M Nadal-NicolásMarta Agudo-Barriuso
Mar 5, 2016·Scientific Reports·Carlos de Torre-MinguelaPablo Pelegrín
Jul 15, 2015·Journal of Dental Research·E S Ramos-JuniorR Coutinho-Silva
Sep 12, 2015·Scientific Reports·Fen HuLeiting Pan
Apr 18, 2012·Journal of Innate Immunity·Nathalia Enes de CamposRobson Coutinho-Silva
Oct 8, 2014·The Journal of Biological Chemistry·Katarina MaherNataša Kopitar-Jerala
Jan 13, 2018·Nature Reviews. Rheumatology·Matthew C WalshYongwon Choi
May 13, 2011·American Journal of Physiology. Cell Physiology·Annarosa Arcangeli
Dec 12, 2018·The EMBO Journal·Enrique Gabandé-RodríguezMaría Dolores Ledesma
Apr 12, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Maria Barberà-CremadesPablo Pelegrín
Sep 15, 2011·Journal of Neurochemistry·Richa HanamsagarTammy Kielian
Oct 18, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tobias HoegenUwe Koedel
Jun 15, 2014·Pharmacological Reviews·Rachael BartlettRonald Sluyter
Dec 29, 2010·Cellular and Molecular Life Sciences : CMLS·Gloria Lopez-CastejónPablo Pelegrín
Apr 22, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Katri NiemiKari K Eklund
Jan 2, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Vincent CompanPablo Pelegrín
Jul 22, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gregory M OrlowskiKenneth L Rock
Sep 18, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sanja ArandjelovicKerri A Mowen
Jul 15, 2018·Nature Reviews. Cancer·Francesco Di VirgilioElena Adinolfi
Jun 28, 2019·Journal of Hematology & Oncology·Shengchao XuChunfang Zhang
Sep 26, 2019·American Journal of Physiology. Lung Cellular and Molecular Physiology·Pierre-Marie AndraultFabien Lecaille
Jan 29, 2020·Proceedings of the National Academy of Sciences of the United States of America·Xiaogang WangJean C Lee
May 3, 2014·The Journal of Biological Chemistry·Hazel EnglandDavid Brough
Jun 8, 2011·International Journal of Immunogenetics·A Al-ShukailiA Al-Ansari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.